Gypenoside XVII confers protection against Abeta25-35-induced neurotoxicity through estrogen receptor-dependent activation of PI3K/Akt pathways, activation of Nrf2/ARE/HO-1 and inactivation of GSK-3beta pathways.
Molecular Weight:
947.2
Purity:
>98% (HPLC)
CAS Number:
[80321-69-3]
Formula:
C48H82O18
Target:
GSK-3beta
* VAT and and shipping costs not included. Errors and price changes excepted